Clinicale relevance of
the shared epitope
Rheumatoid arthritis (RA) or chronic polyarthritis is an intermittent
systemic autoimmune disease which occurs in approx. 1% of the population.
The aetiology of the disease is unknown.
It has been shown for some time by numerous studies that there is
a genetic disposition for RA caused by several alleles of the HLA-DRB1
region. RA is associated with the HLA- DRB1*04 subtypes DRB1*0401,
*0404, *0405, *0408 and also, in some different ethnic groups with
the subtypes DRB1*0101, *0102 and DRB1*1001.
All RA-associated HLA-DRB1 alleles encode in their third hypervariable
region, at postion 70-74, the amino acids QKRAA (*0401), QRRAA (*0404,
*0405, *0408, *0101, *0102) or RRRAA (*1001). This so-called rheumatoid
epitope or shared epitope can be found in approximately 80-90% of
all Caucasian RA patients.
It is not known how the shared epitope in HLA-DRB1*04 supports the
development of RA.
Tests show that, alongside the higher risk of RA, the shared epitope
can also be a prognostic marker for the clinical course and severity
of the disease. In addition to this, numerous studies have shown a
gene-dose effect. Patients homozygous for the shared epitope have
more often a more severe course of disease than those with only one
shared epitope allele (see chart).
|